0
0
10/2/23 at 3:01am
Organization
PRNewswire
38 words
0
Comments
/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today...
You are the first to view
https://www.prnewswire.com/news-releases/chest-2023-poster-demonstrates-the-utility-of-septicyte-rapid-in-antibiotic-administration-and-sepsis-bundle-compliance-301943957.html
Create an account
or login to join the discussion